Nancy Lurker
About Nancy Lurker
Nancy Lurker is the Chief Executive Officer of EyePoint Pharmaceuticals, a position she has held since 2016. She has extensive experience in the pharmaceutical industry, having previously served as CEO of PDI and held various board and executive roles at several notable companies.
Current Role at EyePoint Pharmaceuticals
Nancy Lurker has been serving as the Chief Executive Officer of EyePoint Pharmaceuticals since 2016. Under her leadership, the company focuses on developing innovative therapeutics for eye diseases. Lurker's extensive experience in the pharmaceutical industry contributes to EyePoint's strategic direction and operational management. She has been instrumental in advancing the company's mission to improve patient outcomes through novel drug delivery systems.
Previous Experience at PDI and Auxilium Pharmaceuticals
Before joining EyePoint Pharmaceuticals, Nancy Lurker held the position of Chief Executive Officer and Board Director at PDI from 2008 to 2015. During her tenure, she led the company in healthcare commercialization efforts. Additionally, she served as a Board Director at Auxilium Pharmaceuticals from 2011 to 2015, where she contributed to the company's strategic initiatives and governance.
Educational Background and Qualifications
Nancy Lurker holds a Bachelor of Science degree in Biology from Seattle Pacific University, which she attended from 1976 to 1980. She furthered her education by earning a Master of Business Administration from the University of Evansville, completing her studies from 1988 to 1990. This educational foundation supports her extensive career in the pharmaceutical industry.
Board Memberships and Advisory Roles
In addition to her role at EyePoint Pharmaceuticals, Nancy Lurker serves on the Board of Directors for Aquestive Therapeutics since 2018. She has held various board positions at organizations such as Cancer Treatment Centers of America, Mallinckrodt Pharmaceuticals, and Auxilium Pharmaceuticals. Lurker is also involved in advisory roles for Novo Holdings and the Stanford Medicine Master of Science in Translational Research and Applied Medicine.
Career Progression and Leadership Roles
Nancy Lurker began her career as a Senior Medical Representative at Bristol Myers Squibb. She advanced through various leadership roles, including Senior Vice President and Chief Marketing Officer at Novartis Pharmaceuticals and Group Vice President for Global Primary Care Products at Pharmacia Corporation. Her diverse experience spans multiple facets of the pharmaceutical industry, including marketing, strategic planning, and corporate governance.